» Articles » PMID: 24962612

Dysfunctional Incidental Olfaction in Mild Cognitive Impairment (MCI): An Electroencephalography (EEG) Study

Overview
Journal Brain Sci
Publisher MDPI
Date 2014 Jun 26
PMID 24962612
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Our study provides evidence that Mild Cognitive Impairment (MCI) is associated with olfactory dysfunction on both conscious and non-conscious levels. MCI patients and age-matched controls underwent a face processing task during which sympathy decisions had to be made via button presses. Incidentally, some of the faces were associated with a simultaneously presented odour. Although attention was paid to faces, brain activities were analysed with respect to odour versus no-odour conditions. Behavioural differences were found related to overall face recognition performance, but these were not statistically significant. However, odour-related neurophysiology differed between both groups. Normal controls demonstrated brain activity differences between odour and no-odour conditions that resemble difference activity patterns in healthy young participants as described in a previous magnetoencephalography (MEG) study [1]. They showed odour-related activity patterns between about 160 ms and 320 ms after stimulus onset and between about 640 ms and 720 ms. On the other hand, the patient group did not show any such difference activities. Based on previous research we interpret the early odour-related brain activity pattern in controls as being associated with subliminal olfaction and the later activity pattern with conscious olfaction. None of these were found in MCI patients, although it has to be emphasised that our sample size was rather small. We confirm previous findings about olfactory related dysfunction in patients with MCI and conclude from our findings that even subliminal odour-related information processing is impaired.

Citing Articles

Evaluation of Mild Cognitive Impairment through Perientorhinal/Hippocampal Imaging and Comprehensive Neuropsychological and Psychophysical Assessment.

Invitto S, Boscolo-Rizzo P, Spinato G, Trinchera G, Accogli G, Ciccarese V Brain Sci. 2024; 14(7).

PMID: 39061437 PMC: 11274881. DOI: 10.3390/brainsci14070697.


Olfactory deficit: a potential functional marker across the Alzheimer's disease continuum.

Liu D, Lu J, Wei L, Yao M, Yang H, Lv P Front Neurosci. 2024; 18:1309482.

PMID: 38435057 PMC: 10907997. DOI: 10.3389/fnins.2024.1309482.


Exploratory Study on Chemosensory Event-Related Potentials in Long COVID-19 and Mild Cognitive Impairment: A Common Pathway?.

Invitto S, Boscolo-Rizzo P, Fantin F, Bonifati D, de Filippis C, Emanuelli E Bioengineering (Basel). 2023; 10(3).

PMID: 36978767 PMC: 10045951. DOI: 10.3390/bioengineering10030376.

References
1.
Devanand D, Liu X, Tabert M, Pradhaban G, Cuasay K, Bell K . Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry. 2008; 64(10):871-9. PMC: 2613777. DOI: 10.1016/j.biopsych.2008.06.020. View

2.
Gauthier S, Reisberg B, Zaudig M, Petersen R, Ritchie K, Broich K . Mild cognitive impairment. Lancet. 2006; 367(9518):1262-70. DOI: 10.1016/S0140-6736(06)68542-5. View

3.
Wesson D, Wilson D, Nixon R . Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?. Expert Rev Neurother. 2010; 10(5):633-5. PMC: 3629552. DOI: 10.1586/ern.10.33. View

4.
Walla P, Mayer D, Deecke L, Lang W . How chemical information processing interferes with face processing: a magnetoencephalographic study. Neuroimage. 2004; 24(1):111-7. DOI: 10.1016/j.neuroimage.2004.09.030. View

5.
Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H . Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2007; 29(5):693-706. DOI: 10.1016/j.neurobiolaging.2006.11.014. View